The impact of emphysema in pulmonary fibrosis

European Respiratory Review

Volumn 22, Issue 128, 2013, Pages 153-157

  Cottin, Vincent ^a,b  

^a LOUIS PRADEL HOSPITAL   (France)

^b University Lyon i   (France)

Author keywords

Combined pulmonary fibrosis and emphysema; Emphysema; Idiopathic pulmonary fibrosis; Pulmonary hypertension

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; BRONCHODILATING AGENT; CIGARETTE SMOKE; CORTICOSTEROID; ENDOTHELIN RECEPTOR ANTAGONIST; OXYGEN; PHOSPHODIESTERASE V INHIBITOR; PIRFENIDONE; PROSTANOID;

CLINICAL FEATURE; COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; DISEASE SEVERITY; EXERCISE; EXPOSURE; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPOXEMIA; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG VOLUME; MORBIDITY; MORTALITY; OXYGEN THERAPY; PATHOGENESIS; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SMOKING CESSATION;

COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; EMPHYSEMA; IDIOPATHIC PULMONARY FIBROSIS; PULMONARY HYPERTENSION;

COMORBIDITY; EXERCISE TEST; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; LUNG; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DIFFUSING CAPACITY; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 84878438261     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00000813     Document Type: Review

References (41)

1. Hiwatari N, Shimura S, Takishima T. Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration 1993; 60: 354-358.
2. Doherty MJ, Pearson MG, O'Grady EA, et al. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 1997; 52: 998-1002.
3. Wells AU, King AD, Rubens MB, et al. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med 1997; 155: 1367-1375.
4. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586-593.
5. Bouros D. Combined pulmonary fibrosis and emphysema syndrome. Pneumon 2009; 22: 128-130.
6. Karakatsani A, Papakosta D, Rapti A, et al. Epidemiology of interstitial lung diseases in Greece. Respir Med 2009; 103: 1122-1129.
7. Jankowich MD, Polsky M, Klein M, et al. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 2008; 75: 411-417.
8. Cottin V, Cordier JF. The syndrome of combined pulmonary fibrosis and emphysema. Chest 2009; 136: 1-2.
9. Marten K, Milne D, Antoniou KM, et al. Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol 2009; 19: 1679-1685.
10. Grubstein A, Bendayan D, Schactman I, et al. Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med 2005; 99: 948-954.
11. Usui K, Tanai C, Tanaka Y, et al. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology 2011; 16: 326-331.
12. Kitaguchi Y, Fujimoto K, Hanaoka M, et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010; 15: 265-271.
13. Brillet PY, Cottin V, Letoumelin P, et al. Syndrome emphyse'me des sommets et fibrose pulmonaire des bases combinés (syndrome emphyse'me/fibrose): aspects tomodensitométriques et fonction-nels. [Combined apical emphysema and basal fibrosis syndrome (emphysema/fibrosis syndrome): CT imaging features and pulmonary function tests.]. J Radiol 2009; 90: 43-51.
14. Mura M, Zompatori M, Pacilli AM, et al. The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care 2006; 51: 257-265.
15. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 1990; 84: 365-369.
16. Mejía M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10-15.
17. Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105-111.
18. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-1263.
19. Cottin V, Nunes H, Mouthon L, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63: 295-304.
20. Vehmas T, Kivisaari L, Huuskonen MS, et al. Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers. Eur Respir J 2003; 21: 866-871.
21. Satoh K, Kobayashi T, Misao T, et al. CT assessment of subtypes of pulmonary emphysema in smokers. Chest 2001; 120: 725-729.
22. Daniil Z, Koutsokera A, Gourgoulianis K. Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds. Eur Respir J 2006; 27: 434.
23. Lundblad LK, Thompson-Figueroa J, Leclair T, et al. Tumor necrosis factor-a overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med 2005; 171: 1363-1370.
24. Hoyle GW, Li J, Finkelstein JB, et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol 1999; 154: 1763-1775.
25. Mercer BA, Wallace AM, Brinckerhoff CE, et al. Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter. Am J Respir Cell Mol Biol 2009; 40: 4-12.
26. Cottin V, Reix P, Khouatra C, et al. Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation. Thorax 2011; 66: 918-919.
27. Savale L, Chaouat A, Bastuji-Garin S, et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179: 566-571.
28. Alder JK, Chen JJ, Lancaster L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 2008; 105: 13051-13056.
29. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-664.
30. Wells AU, Hansell DM, Rubens MB, et al. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. Am J Respir Crit Care Med 1997; 155: 1657-1664.
31. Akagi T, Matsumoto T, Harada T, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med 2009; 103: 1209-1215.
32. Aduen JF, Zisman DA, Mobin SI, et al. Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease. Mayo Clin Proc 2007; 82: 48-54.
33. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003; 167: 962-969.
34. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008; 3: 8.
35. Schmidt SL, Nambiar AM, Tayob N, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011; 38: 176-183.
36. Hansell DM. High-resolution computed tomography in the evaluation of fibrosing alveolitis. Clin Chest Med 1999; 20: 739-760.
37. Rogliani P, Mura M, Mattia P, et al. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med 2008; 102: 1753-1761.
38. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
39. Hoeper MM, Halank M, Wilkens H, et al. Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial. Eur Respir J 2013; 41: 853-860.
40. Cottin V. Treatment of pulmonary hypertension in interstitial lung disease: do not throw the baby with the bath water. Eur Respir J 2013; 41: 781-783.
41. Portillo K, Morera J. Combined pulmonary fibrosis and emphysema syndrome: a new phenotype within the spectrum of smoking-related interstitial lung disease. Pulm Med 2012; 2012: 867-870.